title: Giant cell arteritis.
abstract: Whereas giant cell arteritis (GCA) was considered a rare disease 50 years ago, the generalized arteritis is now recognized as an important and significant cause of morbidity in elderly people; its cause and pathogenesis is poorly understood. Glucocorticosteroids are the drug of choice in all clinical types of GCA. In contrast to corticosteroids, nonsteroidal anti-inflammatory drugs have no proven effect on vascular complications to GCA, and cannot be recommended.
authors.affiliation: Division of Rheumatology, Sahlgrenska University Hospital, Göteborg, Sweden.
authors.forename: E
authors.initials: E
authors.lastname: Nordborg
authors.forename: C
authors.initials: C
authors.lastname: Nordborg
authors.forename: B E
authors.initials: BE
authors.lastname: Malmvall
authors.forename: R
authors.initials: R
authors.lastname: Andersson
authors.forename: B A
authors.initials: BA
authors.lastname: Bengtsson
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003937:Diagnosis, Differential; D013700:Giant Cell Arteritis / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D006801:Humans; D015994:Incidence; D009026:Mortality; D011111:Polymyalgia Rheumatica / Q000175:diagnosis
chemical_list: D000305:Adrenal Cortex Hormones